Survey: Less than half of community oncologists use biomarker testing to guide lung cancer care

Less than half of community oncologists surveyed indicated that they use biomarker testing to guide patient discussions compared to 73% of academic clinicians, according to a report issued today at the IASLC 2021 World Conference on Lung Cancer.

Generated by Feedzy